Australia Breaking News

Atomo Diagnostics (ASX:AT1) has secured a material purchase order worth approximately $630,000 from the National Association of People with HIV Australia for the supply of HIV self-tests.

Genetic Signatures (ASX:GSS) has appointed Non-Executive Director Anne Lockwood as its interim Managing Director.

Impact Minerals (ASX:IPT) announced a metallurgical breakthrough, identifying a standalone development pathway to produce high-value Sulphate of Potash and hydrochloric acid from lake clays at its Lake Hope and Salmon Gums projects.

Kali Metals (ASX:KM1) has secured $7 million through a strategic share placement to institutional and sophisticated investors to accelerate its 2026 exploration programs.

Genmin (ASX: GEN), an emerging force in the African iron ore sector, bolstered its market position by securing an 18-month extension on its memoranda of understanding with three of China's most influential steel producers.

Amazon just posted a blockbuster holiday quarter, with Q4 sales surging 14% to a record $213.4 billion as AWS and AI demand powered growth.

Web Travel Group (ASX:WEB) revealed its Spanish subsidiary is the subject of a comprehensive audit by the Spanish Tax Agency.

Immutep (ASX:IMM) announced a significant operational breakthrough in its global TACTI-004 (KEYNOTE-F91) Phase 3 clinical trial.

MGX Resources (ASX:MGX) has completed its acquisition of a 50% interest in the Central Tanami Gold Project joint venture.

PWR Holdings (ASX:PWH) appointed Robert Shore as its new CFO, effective April 21.

Australian biotech firm Terragen (ASX:TGH) announced binding commitments for a $7 million equity raising.

Neuren Pharmaceuticals (ASX:NEU) has commenced dosing in its "Koala" Phase 3 clinical trial.